|

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

RECRUITINGSponsored by University of Latvia
Actively Recruiting
SponsorUniversity of Latvia
Started2019-11-01
Est. completion2022-12
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT04022109

Summary

The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding factors, including lifestyle factors, diet, smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Patients with verified gastric cancer (Group 1 \& 2)
* Patients undergoing or having undergone upper endoscopy according to clinical indications (Group 3 \& 5)
* Average-risk population group aged 40-64 at inclusion without alarm symptoms (Group 4)
* Motivation to participate in the study
* Physical status allowing volatile marker sampling and other procedures within the protocol
* Signed consent

Exclusion Criteria:

* Known other active cancer
* Ventilation problems, airway obstruction
* Unwillingness or inability to co-operate

Conditions5

Atrophic GastritisCancerGastric CancerGastric DysplasiaH Pylori Infection

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.